Government plans to cap drug prices at first point of sale

At present, the government caps prices of essential drugs based on the average ‘price to retailer’ of all brands of any particular medicine with at least 1% market share.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news